《大行報告》匯豐研究微降太古(00019.HK)目標價至59元 評級「持有」
匯豐研究發表研究報告指,太古(00019.HK)的2022財年業績較預期低,其股價一直表現強勁,已經反映了回購的影響,而重新開放的積極作用仍需繼續觀察。該行認為,集團的催化劑尚不明朗,短期的挑戰仍然存在,其目前估值仍處於低位,相信折讓不會再擴大。另外,基於強勁的股息分配,其下行空間有限,維持其「持有」評級,目標價由60元微降至59元。
該行表示,關注集團在飲料業務中的原材料價格上漲,料內地的生產設施重組應能部分抵銷其成本壓力並提高效率,而收購的東南亞資產的盈利貢獻亦開始推動盈利增長。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.